1010 related articles for article (PubMed ID: 15476586)
1. Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3.
Chipoy C; Berreur M; Couillaud S; Pradal G; Vallette F; Colombeix C; Rédini F; Heymann D; Blanchard F
J Bone Miner Res; 2004 Nov; 19(11):1850-61. PubMed ID: 15476586
[TBL] [Abstract][Full Text] [Related]
2. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
Datta NS; Chen C; Berry JE; McCauley LK
J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
[TBL] [Abstract][Full Text] [Related]
3. MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factor.
Lin SK; Kok SH; Yeh FT; Kuo MY; Lin CC; Wang CC; Goldring SR; Hong CY
Arthritis Rheum; 2004 Mar; 50(3):785-93. PubMed ID: 15022320
[TBL] [Abstract][Full Text] [Related]
4. Long term oncostatin M treatment induces an osteocyte-like differentiation on osteosarcoma and calvaria cells.
Brounais B; David E; Chipoy C; Trichet V; Ferré V; Charrier C; Duplomb L; Berreur M; Rédini F; Heymann D; Blanchard F
Bone; 2009 May; 44(5):830-9. PubMed ID: 19168167
[TBL] [Abstract][Full Text] [Related]
5. Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures.
Malaval L; Modrowski D; Gupta AK; Aubin JE
J Cell Physiol; 1994 Mar; 158(3):555-72. PubMed ID: 8126078
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the roles of STAT1 and STAT3 signal transduction pathways in mammalian lens development.
Ebong S; Chepelinsky AB; Robinson ML; Zhao H; Yu CR; Egwuagu CE
Mol Vis; 2004 Feb; 10():122-31. PubMed ID: 14978477
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of osteoprogenitor proliferation and osteoblast differentiation in vitro.
Malaval L; Liu F; Roche P; Aubin JE
J Cell Biochem; 1999 Sep; 74(4):616-27. PubMed ID: 10440931
[TBL] [Abstract][Full Text] [Related]
9. Ghrelin directly regulates bone formation.
Fukushima N; Hanada R; Teranishi H; Fukue Y; Tachibana T; Ishikawa H; Takeda S; Takeuchi Y; Fukumoto S; Kangawa K; Nagata K; Kojima M
J Bone Miner Res; 2005 May; 20(5):790-8. PubMed ID: 15824852
[TBL] [Abstract][Full Text] [Related]
10. Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells.
Shui C; Spelsberg TC; Riggs BL; Khosla S
J Bone Miner Res; 2003 Feb; 18(2):213-21. PubMed ID: 12568398
[TBL] [Abstract][Full Text] [Related]
11. Alphavbeta integrins play an essential role in BMP-2 induction of osteoblast differentiation.
Lai CF; Cheng SL
J Bone Miner Res; 2005 Feb; 20(2):330-40. PubMed ID: 15647827
[TBL] [Abstract][Full Text] [Related]
12. Oncostatin M promotes osteogenesis and suppresses adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells.
Song HY; Jeon ES; Kim JI; Jung JS; Kim JH
J Cell Biochem; 2007 Aug; 101(5):1238-51. PubMed ID: 17226768
[TBL] [Abstract][Full Text] [Related]
13. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone attenuates the transcriptional activity of Runx2 by facilitating its physical association with Stat3beta.
Ziros PG; Georgakopoulos T; Habeos I; Basdra EK; Papavassiliou AG
J Bone Miner Res; 2004 Nov; 19(11):1892-904. PubMed ID: 15476590
[TBL] [Abstract][Full Text] [Related]
15. FK506 enhanced osteoblastic differentiation in mesenchymal cells.
Tang L; Ebara S; Kawasaki S; Wakabayashi S; Nikaido T; Takaoka K
Cell Biol Int; 2002; 26(1):75-84. PubMed ID: 11779223
[TBL] [Abstract][Full Text] [Related]
16. Diosmetin induces human osteoblastic differentiation through the protein kinase C/p38 and extracellular signal-regulated kinase 1/2 pathway.
Hsu YL; Kuo PL
J Bone Miner Res; 2008 Jun; 23(6):949-60. PubMed ID: 18269307
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes.
Shalhoub V; Conlon D; Tassinari M; Quinn C; Partridge N; Stein GS; Lian JB
J Cell Biochem; 1992 Dec; 50(4):425-40. PubMed ID: 1469073
[TBL] [Abstract][Full Text] [Related]
18. Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells.
Nagata T; Kai H; Shibata R; Koga M; Yoshimura A; Imaizumi T
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):588-93. PubMed ID: 12615664
[TBL] [Abstract][Full Text] [Related]
19. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
Malaval L; Liu F; Vernallis AB; Aubin JE
J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050
[TBL] [Abstract][Full Text] [Related]
20. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
